Piatelli Michael J, Wardle Carrie, Blois Joseph, Doughty Cheryl, Schram Brian R, Rothstein Thomas L, Chiles Thomas C
Department of Microbiology, Boston University School of Medicine, Boston Medical Center, Boston, MA 02118, USA.
J Immunol. 2004 Mar 1;172(5):2753-62. doi: 10.4049/jimmunol.172.5.2753.
Phosphatidylinositol 3-kinase (PI-3K) has been linked to promitogenic responses in splenic B cells following B cell Ag receptor (BCR) cross-linking; however identification of the signaling intermediates that link PI-3K activity to the cell cycle remains incomplete. We show that cyclin D2 induction is blocked by the PI-3K inhibitors wortmannin and LY294002, which coincides with impaired BCR-mediated mitogen-activated protein/extracellular signal-related kinase kinase (MEK)1/2 and p42/44ERK phosphorylation on activation residues. Cyclin D2 induction is virtually absent in B lymphocytes from mice deficient in the class I(A) PI-3K p85alpha regulatory subunit. In contrast to studies with PI-3K inhibitors, which inhibit all classes of PI-3Ks, the p85alpha regulatory subunit is not required for BCR-induced MEK1/2 and p42/44ERK phosphorylation, suggesting the contribution of another PI-3K family members in MEK1/2 and p42/44ERK activation. However, p85alpha(-/-) splenic B cells are defective in BCR-induced IkappaB kinase beta and IkappaBalpha phosphorylation. We demonstrate that NF-kappaB signaling is required for cyclin D2 induction via the BCR in normal B cells, implicating a possible link with the defective IkappaB kinase beta and IkappaBalpha phosphorylation in p85alpha(-/-) splenic B cells and their ability to induce cyclin D2. These results indicate that MEK1/2-p42/44ERK and NF-kappaB pathways link PI-3K activity to Ag receptor-mediated cyclin D2 induction in splenic B cells.
磷脂酰肌醇3激酶(PI-3K)与脾脏B细胞在B细胞抗原受体(BCR)交联后产生的促有丝分裂反应有关;然而,将PI-3K活性与细胞周期联系起来的信号转导中间体的鉴定仍不完整。我们发现,PI-3K抑制剂渥曼青霉素和LY294002可阻断细胞周期蛋白D2的诱导,这与BCR介导的丝裂原活化蛋白/细胞外信号调节激酶激酶(MEK)1/2以及激活位点上的p42/44ERK磷酸化受损相吻合。在缺乏I(A)类PI-3K p85α调节亚基的小鼠的B淋巴细胞中,几乎不存在细胞周期蛋白D2的诱导。与抑制所有类型PI-3K的PI-3K抑制剂研究不同,BCR诱导的MEK1/2和p42/44ERK磷酸化不需要p85α调节亚基,这表明另一种PI-3K家族成员在MEK1/2和p42/44ERK激活中发挥作用。然而,p85α(-/-)脾脏B细胞在BCR诱导的IκB激酶β和IκBα磷酸化方面存在缺陷。我们证明,在正常B细胞中,NF-κB信号传导是通过BCR诱导细胞周期蛋白D2所必需的,这暗示了p85α(-/-)脾脏B细胞中IκB激酶β和IκBα磷酸化缺陷与其诱导细胞周期蛋白D2的能力之间可能存在联系。这些结果表明,MEK1/2-p42/44ERK和NF-κB途径将PI-3K活性与脾脏B细胞中抗原受体介导的细胞周期蛋白D2诱导联系起来。